134 related articles for article (PubMed ID: 36031543)
1. Characteristics and Outcomes of Alberta Lymphoma Patients with a History of Immunosuppressive therapy for Autoimmune Conditions.
Kantharia K; Owen C; Stewart D; Yau P; Ghosh S; Dersch-Mills D
Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):894-902. PubMed ID: 36031543
[TBL] [Abstract][Full Text] [Related]
2. Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Kabasawa N; Shiozawa E; Murai S; Homma M; Uesugi Y; Matsui T; Nakata A; Shimada S; Sasaki Y; Baba Y; Watanuki M; Arai N; Fujiwara S; Kawaguchi Y; Tsukamoto H; Uto Y; Yanagisawa K; Hattori N; Sakai H; Harada H; Nakamaki T; Takimoto M; Yamochi-Onizuka T
J Clin Exp Hematop; 2021; 61(3):120-125. PubMed ID: 34511544
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases.
Kaji D; Kusakabe M; Sakata-Yanagimoto M; Makishima K; Suehara Y; Hattori K; Ota Y; Mitsuki T; Yuasa M; Kageyama K; Taya Y; Nishida A; Ishiwata K; Takagi S; Yamamoto H; Asano-Mori Y; Ubara Y; Izutsu K; Uchida N; Wake A; Taniguchi S; Yamamoto G; Chiba S
Br J Haematol; 2021 Nov; 195(4):585-594. PubMed ID: 34558064
[TBL] [Abstract][Full Text] [Related]
4. Primary hepatic lymphoma as other iatrogenic immunodeficiency-related lymphoproliferative disorders: a case report and review of the literature.
Tsuji H; Yoshifuji H; Shindo T; Hishizawa M; Ishida A; Fujimoto M; Kitagori K; Akizuki S; Murakami K; Nakashima R; Hashimoto M; Tanaka M; Ohmura K
Mod Rheumatol Case Rep; 2021 Jan; 5(1):172-177. PubMed ID: 32985951
[TBL] [Abstract][Full Text] [Related]
5. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Tokuhira M; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2019; 59(2):72-92. PubMed ID: 31257348
[TBL] [Abstract][Full Text] [Related]
6. Other iatrogenic immunodeficiency lymphoproliferative disorder induced by corticosteroid used for an autoimmune disorder.
Ito K; Uchino Y; Hirano K; Sekiguchi N
J Int Med Res; 2022 Dec; 50(12):3000605221144149. PubMed ID: 36518090
[TBL] [Abstract][Full Text] [Related]
7. A case of iatrogenic immunodeficiency-associated colonic lymphoma complicating ulcerative colitis.
Suzuki K; Ohe R; Kabasawa T; Aung NY; Yano M; Katsumi S; Yanagiya R; Yamamoto M; Toubai T; Ishizawa K; Yamakawa M
Diagn Pathol; 2020 Apr; 15(1):34. PubMed ID: 32264892
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
[TBL] [Abstract][Full Text] [Related]
9. Iatrogenic immunodeficiency-associated lymphoproliferative disorders of B-cell type that develop in patients receiving immunosuppressive drugs other than in the post-transplant setting.
Momose S; Tamaru JI
J Clin Exp Hematop; 2019; 59(2):48-55. PubMed ID: 31257345
[TBL] [Abstract][Full Text] [Related]
10. [Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
Uchida Y; Hokkoku K; Hatanaka Y; Kikuchi Y; Tashiro H; Sonoo M
Rinsho Shinkeigaku; 2018 Aug; 58(8):485-491. PubMed ID: 30068810
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature.
Rizzi R; Curci P; Delia M; Rinaldi E; Chiefa A; Specchia G; Liso V
Med Oncol; 2009; 26(1):1-9. PubMed ID: 18461290
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer.
Moriya K; Kikuti YY; Carreras J; Kondo Y; Shiraiwa S; Nakamura N
J Clin Exp Hematop; 2020; 60(1):11-16. PubMed ID: 32224560
[TBL] [Abstract][Full Text] [Related]
14. Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype.
Satou A; Tsuzuki T; Nakamura S
J Clin Exp Hematop; 2019; 59(2):56-63. PubMed ID: 31257346
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 expression is associated with the spontaneous regression of patients with methotrexate-associated lymphoproliferative disorders.
Gion Y; Doi M; Nishimura Y; Ikeda T; Filiz Nishimura M; Sakamoto M; Egusa Y; Nishikori A; Fujita A; Iwaki N; Nakamura N; Yoshino T; Sato Y
Cancer Med; 2022 Jan; 11(2):417-432. PubMed ID: 34842351
[TBL] [Abstract][Full Text] [Related]
16. [Oral Mucosal Diffuse Large B-cell Lymphoma Caused by Long-term Oral Methotrexate:Report of One Case].
Liu YQ; Hu XM; Yin Y; Zhang LH; Fu HY; Liu TB; Shen JZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Jun; 43(3):488-493. PubMed ID: 34238428
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types.
Gion Y; Iwaki N; Takata K; Takeuchi M; Nishida K; Orita Y; Tachibana T; Yoshino T; Sato Y
Cancer Sci; 2017 Jun; 108(6):1271-1280. PubMed ID: 28380678
[TBL] [Abstract][Full Text] [Related]
18. Primary Adrenal Lymphoma Possibly Associated With Epstein-Barr Virus Reactivation Due to Immunosuppression Under Methotrexate Therapy.
Ohkura Y; Shindoh J; Haruta S; Kaji D; Ota Y; Fujii T; Hashimoto M; Watanabe G; Matsuda M
Medicine (Baltimore); 2015 Aug; 94(31):e1270. PubMed ID: 26252293
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]